ANTICANCER RES 润色咨询

ANTICANCER RESEARCH

出版年份：1981 年文章数：12142 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：12.0% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2020-12-12 1215c911m91暂无昵称

    国内的稿件几乎都拒绝，不知道为什么。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2020-04-11 148a2d84m51暂无昵称

    请问这个超过12页的收费是怎样的呢？

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2020-02-18 1ddcd3c8m75(暂无匿称)

    有杂志推荐吗？175AUBe6841(暂无昵称) 2020-01-19 发表::
    投了篇病例报道，一周内被拒    175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:
    投了篇病例报道，一周内被拒

    175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2020-01-19 145e8544m41(暂无昵称)

    投了篇病例报道，一周内被拒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-12-29 145e8544m41(暂无昵称)

    有消息么，我也投了138****7523(暂无匿称) 2019-06-29 13:05:00 发表:
    投稿两个半月没有消息

    138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-10-09 120cda4fm26(暂无昵称)

    有谁中了吗？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-06-29 1ddcacc3m23(暂无匿称)

    投稿两个半月没有消息

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-06-29 1ddcacc3m23(暂无匿称)

    投稿两个半月没有消息

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-06-24 Sevenone

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=907371, encodeId=293990e371c4, content=国内的稿件几乎都拒绝，不知道为什么。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dc5d2248408, createdName=1215c911m91暂无昵称, createdTime=Sat Dec 12 19:43:30 CST 2020, time=2020-12-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=588642, encodeId=a90e588642eb, content=请问这个超过12页的收费是怎样的呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3ed55318592, createdName=148a2d84m51暂无昵称, createdTime=Sat Apr 11 00:00:00 CST 2020, time=2020-04-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584932, encodeId=de8e58493240, content=有杂志推荐吗？<span class="quote">175AUBe6841(暂无昵称) 2020-01-19 发表::<br>投了篇病例报道，一周内被拒</span><span class="quote">175AUBe6841(暂无昵称) 2020-01-19 00:00:00 发表:<br>投了篇病例报道，一周内被拒</span>, beContent=175AUBe6841(暂无昵称) 2020-01-19 发表:: 投了篇病例报道，一周内被拒, objectType=tool_impact_factor, channel=null, level=null, likeNumber=221, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7d191652153, createdName=1ddcd3c8m75(暂无匿称), createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583620, encodeId=ffc3583620ab, content=投了篇病例报道，一周内被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Jan 19 00:00:00 CST 2020, time=2020-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582321, encodeId=1409582321f2, content=有消息么，我也投了<span class="quote">138****7523(暂无匿称) 2019-06-29 13:05:00 发表:<br>投稿两个半月没有消息</span>, beContent=138****7523(暂无匿称) 2019-06-29 13:05:00 发表: 投稿两个半月没有消息, objectType=tool_impact_factor, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a0035097545, createdName=145e8544m41(暂无昵称), createdTime=Sun Dec 29 00:00:00 CST 2019, time=2019-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577584, encodeId=add55e7584cb, content=有谁中了吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/09/16/2da242465a0116d6e748bb9e820f7b60.jpg, createdBy=4fc22208461, createdName=120cda4fm26(暂无昵称), createdTime=Wed Oct 09 00:00:00 CST 2019, time=2019-10-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573104, encodeId=a9495e31043f, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=216, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:05:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573103, encodeId=e9855e3103c0, content=投稿两个半月没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2020/02/01/bd696e5dcaaf3eeaa2608f193c9a343a.jpg, createdBy=fd7d1651445, createdName=1ddcacc3m23(暂无匿称), createdTime=Sat Jun 29 13:04:00 CST 2019, time=2019-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572893, encodeId=87a85e2893f8, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review，然后直接拒稿，也没提供任何意见，感觉不好中~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=188, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 16:16:00 CST 2019, time=2019-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572894, encodeId=7e535e289408, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=95672022085, createdName=Sevenone, createdTime=Mon Jun 24 00:00:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-06-24 Sevenone

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：投稿12天，期间一直In Review,然后直接据搞，也没有任何意见，感觉不好中～

    0

共187条页码: 2/19页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分